However, some may take it off-label (meaning for a use the FDA has not approved) to treat bipolar disorder. Various studies ...

Doctors sometimes use lithium to treat schizophrenia. However, it is not a primary treatment method and evidence of its ...

Explore hyposexuality in bipolar disorder, including symptoms like low libido, reduced sexual desire, and difficulty ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

Children and adolescents with bipolar disorder experience severe mood and behavior changes that are extreme and represent a ...

Discover real experiences from our bipolar community on the potential benefits and challenges of ketogenic therapy for mood ...

A sense of impending doom is a sudden, overwhelming feeling that something bad is going to happen even though there's no ...

One of the well known symptoms of clinical depression is episodes of pervasive sadness. But you might not know that there are ...

. Increasing Prevalence: The lifetime prevalence of bipolar disorder is estimated at 1%, with a one-year prevalence of about 0.5% globally. The rise in diagnoses is attributed to greater awareness and ...

“Among the millions of people in the U.S. suffering from the debilitating effects of depression, more than half experience an inadequate response to their current antidepressant, underscoring the ...

RIM-TD open-label extension (OLE) study showed long-term improvement of Tardive Dyskinesia (TD) symptoms from treatment with deutetrabenazine ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...